Jesteś w trybie podpowiedzi Wyłącz

BTEC - iShares Nasdaq US Biotechnology UCITS ETF (IE00BYXG2H39)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.
 
(%)
IE00BYXG2H39
BTEC ISIN
Fundusze notowane na giełdzie (ETF)
Rodzaj funduszu
BlackRock
Usługodawca
9,9 USD
Wartość aktywów netto na akcję | 2026-07-08
2017-10-19
Data uruchomienia
Nie
Wypłata dywidendy
CEOGMS
CFI
BTEC
Symbol giełdowy
Formed
Status
Equity
Obiekt inwestowania
Biotech
Sektor
USA
Zakres geograficzny
Nasdaq Biotechnology Index
Benchmark
0.35 %
Współczynnik całkowitych wydatków
1.131,17 mln USD
Łączna wartość aktywów funduszu | 2026-07-07
Tak
UCITS

Ostatnie dane na
Dodaj do porównania

Notowania (BTEC)

Poznaj najbardziej kompletną bazę danych

1 000 000

obligacje

80 234

akcje

175 910

ETF & Funds

80 000

indeksów

Najskuteczniej kontroluj swój portfel

  • Skaner obligacji
  • Lista do obejrzenia
  • DODATEK Excel

Zmiana dynamiki cen

Fund profile

The iShares Nasdaq US Biotechnology UCITS ETF seeks to replicate as close as possible the price and yield performance of the NASDAQ Biotechnology Index by investing in a portfolio comprised primarily of biotechnology and pharmaceutical equities listed on the NASDAQ

BTEC profile

The iShares Nasdaq US Biotechnology UCITS ETF is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The BlackRock fund’s base currency is USD and the share class was registered 19.10.2017 with unique ISIN - IE00BYXG2H39. Main exchange is London S.E. (USD) and ticker symbol is BTEC. The total expense ratio is 0.35%. The iShares Nasdaq US Biotechnology UCITS ETF pays dividends 0 time(s) per year.

Skład BTEC na 2026-07-07

Papier Wartość
VERTEX PHARMACEUTICALS INC 8,18%
AMGEN INC 7,66%
GILEAD SCIENCES INC 7,11%
REGENERON PHARMACEUTICALS INC 4,66%
ALNYLAM PHARMACEUTICALS INC 2,87%
REVOLUTION MEDICINES INC 2,71%
MODERNA INC 2,12%
BIOGEN INC 2,03%
ILLUMINA INC 1,94%
ROIVANT SCIENCES LTD 1,75%
ROYALTY PHARMA PLC CLASS A 1,71%
ARGENX SE ADR 1,7%
INSMED INC 1,64%
UNITED THERAPEUTICS CORP 1,6%
INCYTE CORP 1,58%
GUARDANT HEALTH INC 1,44%
VIATRIS INC 1,32%
NEUROCRINE BIOSCIENCES INC 1,19%
ASCENDIS PHARMA 1,1%
MEDPACE HOLDINGS INC 1,05%
JAZZ PHARMACEUTICALS PLC 1,04%
BRIDGEBIO PHARMA INC 1,02%
EXELIXIS INC 0,96%
IONIS PHARMACEUTICALS INC 0,96%
AXSOME THERAPEUTICS INC 0,86%
MADRIGAL PHARMACEUTICALS INC 0,84%
SUMMIT THERAPEUTICS INC 0,83%
ARROWHEAD PHARMACEUTICALS INC 0,82%
BIOMARIN PHARMACEUTICAL INC 0,78%
CYTOKINETICS INC 0,78%
BIONTECH SE ADR 0,74%
KRYSTAL BIOTECH INC 0,73%
TEMPUS AI INC CLASS A 0,7%
BEONE MEDICINES AG 0,68%
SANOFI ADR REPRESENTING SA 0,67%
KYMERA THERAPEUTICS INC 0,66%
HALOZYME THERAPEUTICS INC 0,65%
ALKERMES 0,61%
IMMUNITYBIO INC 0,61%
NUVALENT INC CLASS A 0,61%
PROTAGONIST THERAPEUTICS INC 0,6%
PRAXIS PRECISION MEDICINES INC 0,6%
VAXCYTE INC 0,58%
CRINETICS PHARMACEUTICALS INC 0,58%
APOGEE THERAPEUTICS INC 0,56%
IMMUNOVANT INC 0,55%
ABIVAX AMERICAN DEPOSITARY SHARES 0,55%
SPYRE THERAPEUTICS INC 0,54%
RHYTHM PHARMACEUTICALS INC 0,52%
MIRUM PHARMACEUTICALS INC 0,52%
PTC THERAPEUTICS INC 0,49%
COGENT BIOSCIENCES INC 0,46%
SCHOLAR ROCK HOLDING CORP 0,45%
LIGAND PHARMACEUTICALS INC 0,43%
XENON PHARMACEUTICALS INC 0,41%
CG ONCOLOGY INC 0,41%
CRISPR THERAPEUTICS AG 0,39%
ERASCA INC 0,38%
TWIST BIOSCIENCE CORP 0,38%
AMNEAL PHARMACEUTICALS INC CLASS A 0,36%
TRAVERE THERAPEUTICS INC 0,36%
ORUKA THERAPEUTICS INC 0,34%
INDIVIOR PHARMACEUTICALS INC 0,33%
CARIS LIFE SCIENCES INC 0,33%
DEFINIUM THERAPEUTICS INC 0,32%
EDGEWISE THERAPEUTICS INC 0,31%
ACADIA PHARMACEUTICALS INC 0,3%
VERACYTE INC 0,3%
10X GENOMICS INC CLASS A 0,29%
STRUCTURE THERAPEUTICS ADR INC 0,29%
TANGO THERAPEUTICS INC 0,29%
NEWAMSTERDAM PHARMA NV 0,29%
RELAY THERAPEUTICS INC 0,28%
DENALI THERAPEUTICS INC 0,28%
DYNE THERAPEUTICS INC 0,26%
BEAM THERAPEUTICS INC 0,26%
ALUMIS INC 0,24%
IDEAYA BIOSCIENCES INC 0,24%
ULTRAGENYX PHARMACEUTICAL INC 0,23%
ARCUTIS BIOTHERAPEUTICS INC 0,23%
ADAPTIVE BIOTECHNOLOGIES CORP 0,23%
KINIKSA PHARMACEUTICALS INTERNATIO 0,21%
ENLIVEN THERAPEUTICS INC 0,21%
VERA THERAPEUTICS INC CLASS A 0,21%
DISC MEDICINE INC 0,2%
TARSUS PHARMACEUTICALS INC 0,2%
MBX BIOSCIENCES INC 0,2%
GRAIL INC 0,2%
BIOCRYST PHARMACEUTICALS INC 0,19%
SUPERNUS PHARMACEUTICALS INC 0,19%
TREVI THERAPEUTICS INC 0,18%
UNIQURE NV 0,18%
AGIOS PHARMACEUTICALS INC 0,18%
NURIX THERAPEUTICS INC 0,17%
MINERALYS THERAPEUTICS INC 0,17%
KODIAK SCIENCES INC 0,16%
VERICEL CORP 0,16%
INTELLIA THERAPEUTICS INC 0,16%
PHARVARIS N V NV 0,16%
ABCELLERA BIOLOGICS INC 0,16%
Inne - %

Inne ETF & Funds dostawcy usług

Podobne ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    Wartość aktywów netto
    {{ item.expense_ratio }}
    Współczynnik wspólnych wydatków
Należy zarejestrować się , aby uzyskać dostęp.